Telix prostate cancer product approved for Brazil
MELBOURNE: Cancer imaging biotech Telix has been granted permission to use its prostate cancer product
MELBOURNE: Cancer imaging biotech Telix has been granted permission to use its prostate cancer product
FEATURED
How value-based care is changing operations in assisted living sector
Retired teachers fund world travel without touching savings
Architect reveals designs for social housing on regeneration site
Hop, skip and jump for strength and bone density says adherent
Nursing home plans approved for site of elderly housing
Cohousing trend continues to increase its sway over ageing boomers
INNOVATION
